Vicarious Surgical Inc.
General ticker "RBOT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $52.2M (TTM average)
Vicarious Surgical Inc. does not follow the US Stock Market performance with the rate: -9.7%.
Estimated limits based on current volatility of 5.5%: low 2.69$, high 3.00$
Factors to consider:
- Total employees count: 123 (-6.1%) as of 2024
- Top business risk factors: Regulatory and compliance, Market acceptance, Product quality issues, Technological obsolescence, Geopolitical risks
- Current price 31.3% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [6.01$, 19.54$]
- 2025-12-31 to 2026-12-31 estimated range: [3.86$, 13.52$]
Financial Metrics affecting the RBOT estimates:
- Negative: with PPE of -1.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -67.54 <= 0.04
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 68.96 > 64.17
Short-term RBOT quotes
Long-term RBOT plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $80.08MM | $80.67MM | $66.56MM |
| Operating Income | $-80.08MM | $-80.67MM | $-66.56MM |
| Non-Operating Income | $85.23MM | $9.60MM | $3.33MM |
| Interest Expense | $0.20MM | $0.03MM | $0.00MM |
| R&D Expense | $43.90MM | $47.58MM | $40.16MM |
| Income(Loss) | $5.16MM | $-71.07MM | $-63.22MM |
| Profit(Loss)* | $5.16MM | $-71.07MM | $-63.22MM |
| Stockholders Equity | $111.05MM | $97.97MM | $46.70MM |
| Assets | $140.29MM | $119.86MM | $67.72MM |
| Operating Cash Flow | $-61.21MM | $-62.30MM | $-49.96MM |
| Capital expenditure | $5.35MM | $1.67MM | $0.18MM |
| Investing Cash Flow | $-5.35MM | $-45.78MM | $6.86MM |
| Financing Cash Flow | $9.14MM | $44.70MM | $0.01MM |
| Earnings Per Share** | $1.20 | $-14.70 | $-10.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.